Loading...
Loading...
RSLS| Name | Value |
|---|---|
| Revenues | 1,944.0K |
| Cost of Revenue | 779.0K |
| Gross Profit | 1,165.0K |
| Operating Expense | 3,375.0K |
| Operating I/L | -2,210.0K |
| Other Income/Expense | 31.0K |
| Interest Income | 0.0K |
| Pretax | -2,179.0K |
| Income Tax Expense | 14.0K |
| Net Income/Loss | -2,193.0K |
ReShape Lifesciences Inc. is a medical device company that offers products and services for managing and treating obesity and metabolic diseases globally. The company's product portfolio includes the Lap-Band System for long-term treatment of severe obesity, ReShape Vest system for minimally invasive weight loss, ReShapeCare virtual health coaching program, and ReShape Diabetes Bloc-Stim Neuromodulation for type 2 diabetes mellitus. Additionally, it provides the Obalon Balloon System, a swallowable capsule for tracking and placing balloons. The company generates revenue through the sale of its medical devices and services, catering to obese and morbidly obese patients seeking weight management solutions.
